David N. Taylor

H. Dupont, David N. Taylor, P. Okhuysen, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Rifaximin treatment of pathogen-negative travelers' diarrhea.

H. Dupont, David N. Taylor, R. Steffen, 2007, Journal of travel medicine.

Vaccines for Prevention of Enteric Bacterial Infections Caused by Salmonellae

David N. Taylor, S. Szu, R. Schneerson, 1993 .

The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron

B. Wiedenheft, S. Walk, David N. Taylor, 2022, Viruses.

volunteers.conjugate vaccines in Israeli Safety and immunogenicity of investigational

Manfred S. Green, J. Shiloach, David N. Taylor, 2013 .

Two Studies Evaluating the Safety and Immunogenicity of a Live, Attenuated Shigella flexneri 2a Vaccine (SC602) and Excretion of Vaccine Organisms in North American Volunteers

M. Wolf, David N. Taylor, M. Venkatesan, 2004, Infection and Immunity.

Randomized, Controlled Human Challenge Study of the Safety, Immunogenicity, and Protective Efficacy of a Single Dose of Peru-15, a Live Attenuated Oral Cholera Vaccine

K. Killeen, J. Bean, David N. Taylor, 2002, Infection and Immunity.

Safety and Immunogenicity of Two Different Lots of the Oral, Killed Enterotoxigenic Escherichia coli-Cholera Toxin B Subunit Vaccine in Israeli Young Adults

Manfred S. Green, D. Cohen, A. Svennerholm, 2000, Infection and Immunity.

Vibrio cholerae O139 Conjugate Vaccines: Synthesis and Immunogenicity of V. cholerae O139 Capsular Polysaccharide Conjugates with Recombinant Diphtheria Toxin Mutant in Mice

J. Shiloach, David N. Taylor, S. Szu, 2000, Infection and Immunity.

Epidemiology of Travelers' Diarrhea

H. Dupont, David N. Taylor, J. Sanders, 2019, Travel Medicine.

Chapter 16 – Epidemiology of Travelers' Diarrhea

David N. Taylor, J. Sanders, M. Riddle, 2008 .

Noroviruses as a Cause of Diarrhea in Travelers to Guatemala, India, and Mexico

N. Ajami, H. Dupont, David N. Taylor, 2007, Journal of Clinical Microbiology.

78. Oral Norovirus Vaccination in Humans Induces Plasmablast B-Cell Expansion and Follicular T-Cell Activation Comparable to Natural Infection

David N. Taylor, Roberto Mateo, Shaily J. Garg, 2019, Open Forum Infectious Diseases.

Posttreatment Follow-Up of Helicobacter pylori Infection Using a Stool Antigen Immunoassay

T. Monath, R. Gilman, L. Cabrera, 2001, Clinical Diagnostic Laboratory Immunology.

Campylobacter transmission in a Peruvian shantytown: a longitudinal study using strain typing of campylobacter isolates from chickens and humans in household clusters.

R. Gilman, L. Cabrera, M. Zimic, 2003, The Journal of infectious diseases.

Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.

H. Dupont, David N. Taylor, R. Steffen, 2008, Journal of travel medicine.

Transcutaneous immunization: A human vaccine delivery strategy using a patch

C. Alving, G. Glenn, David N. Taylor, 2000, Nature Medicine.

Effects of nutritional status on diarrhea in Peruvian children.

L. Moulton, R. Black, R. Gilman, 2002, The Journal of pediatrics.

Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge.

David N. Taylor, A. Durbin, A. L. Bourgeois, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibodies toShiga Holotoxin andtoTwoSynthetic Peptides oftheB Subunit inSeraofPatients with Shigella dysenteriae 1Dysentery

M. Bennish, D. Cohen, G. Losonsky, 1992 .

Typhoid vaccines come of age

M. Levine, David N. Taylor, C. Ferreccio, 1989, The Pediatric infectious disease journal.

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

J. Treanor, Langzhou Song, David N. Taylor, 2010, Vaccine.

Etiology of Diarrheal Disease Among Travelers and Foreign Residents in Nepal

David N. Taylor, B. Ungar, D. Shlim, 1989 .

Medications for the prevention and treatment of travellers' diarrhea.

D. Hamer, David N. Taylor, D. Shlim, 2017, Journal of travel medicine.

Disease Among Peruvian Children Acute Helicobacter pylori Infection Is Followed by an Increase in Diarrheal

D. Passaro, R. Gilman, L. Cabrera, 2013 .

Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.

J. O’Neill, David N. Taylor, A. L. Bourgeois, 2006, Vaccine.

Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).

J. Treanor, David N. Taylor, T. Fitzgerald, 2011, Vaccine.

Country‐specific constancy by age in cagA+ proportion of Helicobacter pylori infections

E. Kuipers, M. Blaser, N. Bhat, 1997, International journal of cancer.

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.

W. Keitel, David N. Taylor, H. Keyserling, 2006, Vaccine.

Expanded Safety and Immunogenicity of a Bivalent, Oral, Attenuated Cholera Vaccine, CVD 103-HgR Plus CVD 111, in United States Military Personnel Stationed in Panama

M. Levine, C. Tacket, G. Losonsky, 1999, Infection and Immunity.

Poorly absorbed antibiotics for the treatment of traveler's diarrhea.

David N. Taylor, David N Taylor, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults.

David N. Taylor, Francesco Berlanda Scorza, R. Wahid, 2016, Vaccine.

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score

D. Sack, David N. Taylor, A. L. Bourgeois, 2018, PloS one.

Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate.

M. Wolf, David N. Taylor, M. Venkatesan, 2008, Vaccine.

What Will Travel Medicine Look Like in the COVID-19 Pandemic Era?

David N. Taylor, B. Connor, D. Shlim, 2020, Journal of travel medicine.

Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7".

W. Keitel, David N. Taylor, H. Keyserling, 2007, Vaccine.

Two new Escherichia coli O groups: O172 from »Shiga‐like» toxin II‐producing strains (EHEC) and O173 from enteroinvasive E. coli (EIEC)

I. Wachsmuth, David N. Taylor, P. Echeverria, 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Human caliciviruses as a cause of severe gastroenteritis in Peruvian children.

R. Glass, U. Parashar, R. Gilman, 2004, The Journal of infectious diseases.

Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development

R. Baric, David N. Taylor, A. Sims, 2019, The Journal of infectious diseases.

Parasitic infections of the gastrointestinal tract.

David N. Taylor, D. N. Taylor, D. Katz, 2001, Gastroenterology clinics of North America.

Nitric oxide production during Vibrio cholerae infection.

David N. Taylor, E. Jaimes, L. Raij, 1997, American journal of physiology. Gastrointestinal and liver physiology.

Etiology of Urethritis in Thai Men

David N. Taylor, A. Chitwarakorn, C. Ariyarit, 1989, Sexually Transmitted Diseases.

Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.

R. Gilman, David N. Taylor, P. Echeverria, 2000, The Journal of infectious diseases.

Characterization of Vibrio cgolerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru

M. Albert, David N. Taylor, T. Shimada, 1995, Journal of clinical microbiology.

Immune Response, Ciprofloxacin Activity, and Gender Differences after Human Experimental Challenge by Two Strains of Enterotoxigenic Escherichia coli

M. Wolf, E. Hall, David N. Taylor, 2006, Infection and Immunity.

Typhoid and paratyphoid fever in 192 hospitalized children in Thailand.

David N. Taylor, D. N. Taylor, U. Thisyakorn, 1987, American journal of diseases of children.

A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children.

R. Black, R. Gilman, L. Cabrera, 1999, The Journal of pediatrics.

Salmonella dublin infections in the United States, 1979-1980.

David N. Taylor, D. N. Taylor, R. Feldman, 1982, The Journal of infectious diseases.

A comparative field study of radiolabeled and enzyme-conjugated synthetic DNA probes for the diagnosis of falciparum malaria.

H. Webster, David N. Taylor, P. Echeverria, 1988, The American journal of tropical medicine and hygiene.

The epidemiology of Helicobacter pylori infection.

M. Blaser, David N. Taylor, D. N. Taylor, 1991, Epidemiologic reviews.

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

David N. Taylor, L. Stanberry, C. Turley, 2011, Vaccine.

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits

A. Svennerholm, David N. Taylor, R. Meza, 1994, The Lancet.

Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand.

M. Levine, C. Hoge, Y. Lim, 1992, The Journal of infectious diseases.

Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' Diarrhea.

H. Dupont, A. Svennerholm, David N. Taylor, 1995, Journal of travel medicine.

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.

D. Spriggs, J. Mekalanos, K. Killeen, 1995, The Journal of infectious diseases.

Systemic Pharmacokinetics of Rifaximin in Volunteers with Shigellosis

David N. Taylor, A. Durbin, A. L. Bourgeois, 2007, Antimicrobial Agents and Chemotherapy.

Helicobacter pylori-associated chronic atrophic gastritis involving the gastric body and severe disease byVibrio cholerae

E. Gotuzzo, David N. Taylor, M. Kosek, 2008 .

Chronic diarrhea in the returned traveler.

David N. Taylor, D. N. Taylor, B. Connor, 1999, The Medical clinics of North America.

Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial.

David N. Taylor, P. Echeverria, D. N. Taylor, 1991, Annals of internal medicine.

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

C. Hoge, David N. Taylor, P. Echeverria, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees.

B. Feighner, David N. Taylor, D. N. Taylor, 2000, Emerging infectious diseases.

Isolation of group 2 aerotolerant Campylobacter species from Thai children with diarrhea.

David N. Taylor, P. Echeverria, D. N. Taylor, 1991, The Journal of infectious diseases.

Identification by DNA hybridization of enterotoxigenic Escherichia coli in a longitudinal study of villages in Thailand.

David N. Taylor, P. Echeverria, D. N. Taylor, 1985, The Journal of infectious diseases.

Seroprevalence of Helicobacter pylori infections in Thailand.

M. Blaser, B. Dunn, W. Baze, 1990, The Journal of infectious diseases.

Lactulose–Mannitol Intestinal Permeability Test in Children With Diarrhea Caused by Rotavirus and Cryptosporidium

R. Glass, R. Gilman, David N. Taylor, 2000, Journal of Pediatric Gastroenterology and Nutrition.

Seroprevalence of Helicobacter pylori infections in a cohort of US Army recruits.

P. Kelley, David N. Taylor, D. N. Taylor, 1994, American journal of epidemiology.

Middle East. coli isolated from U.S. troops deployed to the Characterization of enterotoxigenic Escherichia

D. Maneval, M. Wolf, M. Levine, 2013 .

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru

M. Levine, C. Tacket, G. Losonsky, 1997, Infection and immunity.